123 related articles for article (PubMed ID: 31319587)
1. Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer.
Kumar J; Chudasama D; Roberts C; Kubista M; Sjöback R; Chatterjee J; Anikin V; Karteris E; Hall M
Cells; 2019 Jul; 8(7):. PubMed ID: 31319587
[No Abstract] [Full Text] [Related]
2. High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers.
Dent BM; Ogle LF; O'Donnell RL; Hayes N; Malik U; Curtin NJ; Boddy AV; Plummer ER; Edmondson RJ; Reeves HL; May FE; Jamieson D
Int J Cancer; 2016 Jan; 138(1):206-16. PubMed ID: 26178530
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker.
Zhang X; Li H; Yu X; Li S; Lei Z; Li C; Zhang Q; Han Q; Li Y; Zhang K; Wang Y; Liu C; Mao Y; Wang X; Irwin DM; Guo H; Niu G; Tan H
Cell Physiol Biochem; 2018; 48(5):1983-1994. PubMed ID: 30092594
[TBL] [Abstract][Full Text] [Related]
4. Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Fagotti A; Ferrandina G; Vizzielli G; Fanfani F; Gallotta V; Chiantera V; Costantini B; Margariti PA; Gueli Alletti S; Cosentino F; Tortorella L; Scambia G
Eur J Cancer; 2016 May; 59():22-33. PubMed ID: 26998845
[TBL] [Abstract][Full Text] [Related]
5. Amplification of GNAS may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer.
Tominaga E; Tsuda H; Arao T; Nishimura S; Takano M; Kataoka F; Nomura H; Hirasawa A; Aoki D; Nishio K
Gynecol Oncol; 2010 Aug; 118(2):160-6. PubMed ID: 20537689
[TBL] [Abstract][Full Text] [Related]
6. Detection of tumor circulating cells by cytokeratin-20 in the blood of patients with granulosa cell tumors.
Altaras MM; Klein A; Zemer R; Zimlichman S; Bernheim J; Fishman A
Gynecol Oncol; 2002 Sep; 86(3):330-6. PubMed ID: 12217756
[TBL] [Abstract][Full Text] [Related]
7. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
[TBL] [Abstract][Full Text] [Related]
8. Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients.
Sapi E; Okpokwasili NI; Rutherford T
Cancer Detect Prev; 2002; 26(2):158-67. PubMed ID: 12102151
[TBL] [Abstract][Full Text] [Related]
9. Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs).
Pearl ML; Dong H; Tulley S; Zhao Q; Golightly M; Zucker S; Chen WT
Gynecol Oncol; 2015 May; 137(2):229-38. PubMed ID: 25769657
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer.
Lee M; Kim EJ; Cho Y; Kim S; Chung HH; Park NH; Song YS
Gynecol Oncol; 2017 May; 145(2):361-365. PubMed ID: 28274569
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer.
Friedlander TW; Ngo VT; Dong H; Premasekharan G; Weinberg V; Doty S; Zhao Q; Gilbert EG; Ryan CJ; Chen WT; Paris PL
Int J Cancer; 2014 May; 134(10):2284-93. PubMed ID: 24166007
[TBL] [Abstract][Full Text] [Related]
13. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM
Akhter MZ; Sharawat SK; Kumar V; Kochat V; Equbal Z; Ramakrishnan M; Kumar U; Mathur S; Kumar L; Mukhopadhyay A
Oncogene; 2018 Apr; 37(16):2089-2103. PubMed ID: 29379166
[TBL] [Abstract][Full Text] [Related]
14. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer.
Judson PL; Geller MA; Bliss RL; Boente MP; Downs LS; Argenta PA; Carson LF
Gynecol Oncol; 2003 Nov; 91(2):389-94. PubMed ID: 14599871
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
Huang HB; Ge MJ
Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
[TBL] [Abstract][Full Text] [Related]
16. Nuclear β-catenin positivity as a predictive marker of long-term survival in advanced epithelial ovarian cancer.
Nagy B; Tóth L; Molnár P; Méhes G; Thurzó L; Póka R; Hernádi Z
Pathol Res Pract; 2017 Aug; 213(8):915-921. PubMed ID: 28651933
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer.
Carter JH; Deddens JA; Mueller G; Lewis TG; Dooley MK; Robillard MC; Frydl M; Duvall L; Pemberton JO; Douglass LE
Br J Cancer; 2018 Aug; 119(4):462-470. PubMed ID: 30057405
[TBL] [Abstract][Full Text] [Related]
19. ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.
Kuhlmann JD; Wimberger P; Bankfalvi A; Keller T; Schöler S; Aktas B; Buderath P; Hauch S; Otterbach F; Kimmig R; Kasimir-Bauer S
Clin Chem; 2014 Oct; 60(10):1282-9. PubMed ID: 25015375
[TBL] [Abstract][Full Text] [Related]
20. [Detection of tumor cells in peripheral blood for patients with ovarian epithelial carcinoma].
Liu K; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):301-3. PubMed ID: 11326940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
